Beyond Somatostatin Analogs: Emerging Therapies for Refractory Carcinoid Syndrome
Beyond Somatostatin Analogs: Emerging Therapies for Refractory Carcinoid Syndrome Somatostatin analogs (SSAs) have long been the cornerstone of medical management for Carcinoid Syndrome, effectively controlling hormonal symptoms like flushing and diarrhea, and in some cases, even slowing tumor growth. However, a significant proportion of patients experience refractory symptoms or disease...
0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
Patrocinado
Patrocinado
Patrocinado
google-site-verification: google037b30823fc02426.html